Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
 
 
 
Blog Home
Bob Carey
Chief Market Strategist
Bio
X •  LinkedIn
 

  The Performance Of Health Care Stocks In The Recent Correction & Subsequent Rebound
Posted Under: Sectors
Supporting Image for Blog Post

 
Supporting Image for Blog Post

 

View from the Observation Deck  

  1. Health Care is the only sector that has outperformed the S&P 500 Index in each of the past five years, including this one, according to S&P Capital IQ. It is a top theme in the market, in our opinion.
  2. From 12/31/10-10/19/15, the S&P 500 indices in the chart posted the following cumulative total returns (Bloomberg):  301.7% (Biotechnology); 252.3% (Managed Health Care); 143.5% (Health Care); 127.0% (Pharmaceuticals); and 90.6% (Health Care Equipment). The S&P 500 Index was up 79.01% over the same period.
  3. One of the interesting developments depicted in the charts is the performance of Managed Health Care. These stocks went down the least in the correction, yet have rallied the most in the rebound.
  4. Of the indices in the charts, Managed Health Care was by far the worst performer in 2008, posting a total return of -55.04%, according to Bloomberg. This is back when the groundwork was being laid for the Affordable Care Act, and there was some fear in the market about the potential for a single-payer insurance system. The Affordable Care Act was not signed into law until 2010.
  5. In addition to the recent correction in the S&P 500 Index (see top chart), at least one presidential candidate has targeted one specific drug company to attack the high cost of some prescription medicines. While such comments could be weighing on the performance of the pharmaceutical and biotechnology sectors in the near-term, perhaps out of a fear of government price caps or curbs, we believe these stocks will trade on fundamentals over time. 
  6. As of 10/20/15, the estimated price-to-earnings ratios on the S&P 500 Health Care Index for 2015 and 2016 were 16.82 and 15.17, respectively, below the 5-year average of 17.22, according to Bloomberg.

This chart is for illustrative purposes only and not indicative of any actual investment. The illustration excludes the effects of taxes and brokerage commissions and other expenses incurred when investing. Investors cannot invest directly in an index. There can be no assurance that any of the projections cited will occur. The S&P 500 Health Care Index, S&P 500 Biotechnology Index, S&P 500 Health Care Equipment Index, S&P 500 Managed Health Care Index and S&P 500 Pharmaceuticals Index are all capitalization-weighted indices focused on either the health care sector or its subsectors. The S&P 500 Index is a capitalization-weighted index comprised of 500 stocks used to measure large-cap U.S. stock market performance.

To Download a PDF of this post, please click here.

Posted on Tuesday, October 20, 2015 @ 3:24 PM • Post Link Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
MARKET ANALYSIS
Market Commentary and Analysis
Market Commentary Video
Monthly Talking Points
Quarterly Newsletter
Market Observations
Subscribe To Receive Email
 


 PREVIOUS POSTS
How to Get the Attention of the Financial Media
Just When You Thought It Was Over…
U.S. Oil & Gas Rig Counts Continue To Fall
Stock Dividend Increases Dipped (Y-O-Y) After Strong Rebound From 2008-2009 Recession Levels
Sector Performance In The Recent Correction And Subsequent Rebound
Recovery
The Outlook For Corporate Earnings Remains Positive
The Slowdown In Global Growth Is A Hot Topic Of Late
Investors Have Had A Big Appetite For Foreign Equities So Far In 2015
The Prospects For Owning Natural Gas Stocks Over A Particular 5-Month Stretch
Archive
Skip Navigation Links.
Expand 20242024
Expand 20232023
Expand 20222022
Expand 20212021
Expand 20202020
Expand 20192019
Expand 20182018
Expand 20172017
Expand 20162016
Expand 20152015
Expand 20142014
Expand 20132013
Expand 20122012
Expand 20112011

Search by Topic
Skip Navigation Links.

 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2024 All rights reserved.